MARKET

FBIOP

FBIOP

Fortress Biotech Inc
NASDAQ
16.60
-0.17
-1.01%
Closed 16:00 03/28 EDT
OPEN
17.39
PREV CLOSE
16.77
HIGH
17.39
LOW
16.51
VOLUME
12.83K
TURNOVER
0
52 WEEK HIGH
18.91
52 WEEK LOW
5.77
MARKET CAP
56.89M
P/E (TTM)
-1.3510
1D
5D
1M
3M
1Y
5Y
Fortress Biotech Inc reports results for the quarter ended in December - Earnings Summary
Fortress Biotech Inc reports results for the quarter ended in December. Revenue rose 21.6% to $19.95 million from a year ago. The company reported a quarterly adjusted loss of 53 cents per share. The mean expectation of five analysts was for a loss of $1.97.
Reuters · 10h ago
Fortress Biotech Inc <FBIO.OQ> expected to post a loss of $1.97 a share - Earnings Preview
Fortress Biotech Inc expected to post a loss of $1.97 a share. The company is expected to report a 9.2% decrease in quarterly revenue to $14.894 million. Wall Street expects the company to report results on March 28.
Reuters · 2d ago
Weekly Report: what happened at FBIOP last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at FBIOP last week (0311-0315)?
Weekly Report · 03/18 10:00
Health Rounds: CAR-T therapy shows early promise against brain cancer
Health Rounds: CAR-T therapy shows early promise against brain cancer. A blood test for detecting colorectal cancer that was as accurate as current commercial home tests. Early trials hint at benefit ofCAR-T cells in glioblastoma. The therapy shrank tumors in three separate early-stage trials.
Reuters · 03/14 17:58
BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Equitrans Midstream, Crypto-linked stocks
U.S. Stock index futures slip on Monday as investors await key inflation figures this week. Mixed jobs data reinforced expectations that the Fed will begin easing by mid-year. Equitrans Midstream Corp rises after merger with EQT Corp. Crypto-linked stocks jump as bitcoin hits record high.
Reuters · 03/11 11:54
Weekly Report: what happened at FBIOP last week (0304-0308)?
Weekly Report · 03/11 09:58
Weekly Report: what happened at FBIOP last week (0226-0301)?
Weekly Report · 03/04 10:00
More
About FBIOP
Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an oral capsule for the treatment of severe recalcitrant nodular acne. Amzeeq (minocycline 4%) topical foam is a topical minocycline treatment for the inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and children nine years and older. Zilxi (minocycline 1.5%) is a topical foam and a topical minocycline treatment for inflammatory lesions of rosacea in adults. Ximino (minocycline hydrochloride) is an oral minocycline drug for the treatment of moderate to severe acne.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIOP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIOP stock methods without spending real money on the virtual paper trading platform.